SLRX icon

Salarius Pharmaceuticals
SLRX

Overview Fund Trends Analyst Outlook Journalist POV

5 hedge funds and large institutions have $7.55K invested in Salarius Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $
Holders
5
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$2.32K
2
+$199
3
+$148
4
Bank of America
Bank of America
North Carolina
+$26
5
TRCT
Tower Research Capital (TRC)
New York
+$22

Top Sellers

1
-$54.1K
2
-$17
3
-$2
4
Wells Fargo
Wells Fargo
California
-$2
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$4.59K
2
$2.32K
3
$375
4
$232
5
$26
6
$10
7
$1
8
–
9
–